Search results
BI Asset Management Fondsmaeglerselskab A S Has $888,000 Position in Axon Enterprise, Inc....
ETF DAILY NEWS· 3 days ago(NASDAQ:AXON – Free Report) by 30.1% during the fourth quarter, according to its most recent Form...
Great Lakes Advisors LLC Has $1.11 Million Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
ETF DAILY NEWS· 4 days agoGreat Lakes Advisors LLC trimmed its holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 50.8% during the fourth quarter, according to its most recent ...
Amalgamated Bank Has $108,000 Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)
ETF DAILY NEWS· 2 days agoAmalgamated Bank lessened its stake in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 7.5% in the 4th quarter, according to its most recent disclosure with the Securities ...
Jump Financial LLC Has $317,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)
ETF DAILY NEWS· 12 hours agoThe institutional investor owned 11,300 shares of the biopharmaceutical company’s stock after selling 191,700 shares during the period. Jump Financial LLC’s holdings in Royalty ...
HC Wainwright Weighs in on Oramed Pharmaceuticals Inc.’s Q3 2024 Earnings (NASDAQ:ORMP)
ETF DAILY NEWS· 4 days agoOramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) – Analysts at HC Wainwright cut their Q3 2024 EPS estimates for shares of Oramed Pharmaceuticals in a research report ...
Lindsay A. Md Rosenwald Buys 10,000 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) Stock
ETF DAILY NEWS· 5 days agoFortress Biotech, Inc. (NASDAQ:FBIO – Get Free Report) CEO Lindsay A. Md Rosenwald purchased 10,000 shares of Fortress Biotech stock in a transaction that ...
Andrew Schwendenman Sells 2,298 Shares of Replimune Group, Inc. (NASDAQ:REPL) Stock
ETF DAILY NEWS· 5 days agoReplimune Group, Inc. (NASDAQ:REPL – Get Free Report) CAO Andrew Schwendenman sold 2,298 shares of the business’s stock in a transaction dated Thursday, ...
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
ETF DAILY NEWS· 11 hours agoRobeco Institutional Asset Management B.V. lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The fund
Brainstorm Cell Therapeutics (NASDAQ:BCLI) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 1 day agoThe firm issued a hold rating on the biotechnology company’s stock. Brainstorm Cell Therapeutics Trading Down 7.0 % Shares of Brainstorm Cell Therapeutics ...
Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM) Receives $25.60 Consensus Target Price from...
ETF DAILY NEWS· 3 days agoShares of Actinium Pharmaceuticals, Inc. (NYSEAMERICAN:ATNM – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are presently covering the ...